Dr. Natalia Birkemeier

Selbstständig, Consultant, BioPharma First Consultancy

Nijmegen, Niederlande

Fähigkeiten und Kenntnisse

(Bio)Pharmaceuticals
Pharmaceutical Prod Dev
Clinical Research
Business Networking
Private Equity
Venture Capital
Medical Devices
Technology Transfer
Medicinal Chemistry
Life Science
Drug Safety
ADRs
Project Management

Werdegang

Berufserfahrung von Natalia Birkemeier

  • Bis heute 14 Jahre und 6 Monate, seit 2010

    Consultant

    BioPharma First Consultancy

    BioPharma First (former PharmaNature Consultancy Drug Safety, Regulatory & Scientific Advice) supports investors across the EU in their financial decisions. Main work covers opportunity evaluation, technology assesment, market analysis, industry insights, target selection, business models & strategy characteristics.

  • 4 Monate, Jan. 2018 - Apr. 2018

    MBA intern I Consultant

    Gilde Healthcare Partners
  • 2013 - 2014

    Project Leader

    Future Diagnostics BV

  • 2011 - 2012

    BD Manager | Project Leader | Lecturer

    Avans University of Aplied Sciences

  • 2006 - 2010

    Project Leader | Scientist

    Synthon BV

  • 1 Jahr und 1 Monat, Okt. 2004 - Okt. 2005

    Post-doc Fellow

    Free University Amsterdam

Ausbildung von Natalia Birkemeier

  • 2016 - 2018

    Business Administration

    Cracow University of Economics

    Post-graduate MBA/European Management Study (ECTS: 131) Thesis: Strategic mergers, acquisitions and joint ventures in the pharmaceutical sector in the context of financial analysis of the enterprise (grade achieved: very good)

  • 2015 - 2016

    Clinical Trials, Methodology and Management

    Jagiellonian University, Krakow

  • 4 Jahre und 10 Monate, Okt. 1999 - Juli 2004

    Chemie

    Universiteit van Amsterdam

  • 4 Jahre und 11 Monate, Sep. 1994 - Juli 1999

    Chemie

    Uniwersytet Wrocławski

Sprachen

  • Englisch

    Fließend

  • Polnisch

    Muttersprache

  • Niederländisch

    Fließend

  • Deutsch

    Gut

Interessen

Pharma
Clinical Research
(Novel) Therapies
Pharmaceutical Prod Dev
Private Equity
Venture Capital
Sport
Photography
Writing

21 Mio. XING Mitglieder, von A bis Z